Oracle closes $10 billion stock sale and $10 billion notes offering
Oracle issued 86,206,897 shares of common stock under an underwriting agreement dated November 2, 2026, with the offering closing on November 4, 2026. It also sold $10 billion of notes in five tranches maturing from 2029 to 2046, with net proceeds for general corporate purposes, which may include capital expenditures, debt repayment, acquisitions, dividends or buybacks. Shareholders face dilution from the new shares, and the filing does not state the net proceeds or how they will be allocated.
Key points
- Common stock: 86,206,897 shares sold under an underwriting agreement with BofA Securities, Inc. as representative, closed November 4, 2026
- Notes issued November 4, 2026: 7.000% due 2029 ($2.0 billion), 7.450% due 2031 ($1.75 billion), 7.850% due 2033 ($2.25 billion), 8.000% due 2037 ($2.5 billion), 8.650% due 2046 ($1.5 billion)
- Net proceeds from both offerings will fund general corporate purposes, which may include capital expenditures, debt repayment, acquisitions and shareholder payouts
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 7, 2026, 11:17 PM ET, from the text of the filing and its press-release exhibits only.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.